zyuzino.loc.city

Indicated for the reduction of atherosclerotic events (myocardial infarction, stroke and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease.

Información de Contacto

En catálogos

Musharof Chy21/02/20251 min de lecturaActualizado hace 12 meses